MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing Oct 19 • 5 min read Mind Medicine (MindMed) Inc. announced that it has filed a preliminary short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec.
Universal Ibogaine Retains Westmount Park Investments for Corporate Financial Advisory Services Oct 16 • 4 min read Universal Ibogaine Inc. announced it has entered a strategic agreement with Westmount Park Investments to receive financial advice on an ongoing basis.
Mind Cure Announces Geoff Belair as Chief Technology Officer Oct 15 • 7 min read Mind Cure Health Inc. announced the hiring of Geoff Belair as the company’s new Chief Technology Officer.
Pharmather Announces Exclusive License Agreement with the University of Arizona for the Commercialization of Ketamine in the Treatment of Parkinson’s Disease Oct 15 • 6 min read Pharmather Inc. announced that the company has entered into an agreement with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson’s disease.
Silo Pharma, Inc. (SILO) Announces Successful Uplisting To the OTCQB Venture Market Oct 15 • 3 min read Silo Pharma, Inc. announced its successful uplisting from the OTC Pink Market to the OTCQB® Venture Market.